can type 1 diabetics use glp 1 Is GLP-1 the Same as Ozempic? Rafael Olartecoechea GLP-1R and Diabetes

Pharmacists Perspective Faryal Faisal, PharmD SURMOUNT-5 is significant because it was a direct, randomised comparison not two separate trials being indirectly compared

Diabetes 48:8693

For detailed comparison of the diabetes versions, see our Mounjaro vs Ozempic guide

By Product: Ozempic dominates, Tirzepatide products growing fastest Ozempic (semaglutide 0.5mg/1mg/2mg weekly subcutaneous injection) dominated the GLP-1 receptor agonist market with approximately 35.12% market share in 2025, driven by its combination of robust clinical efficacy data, early market entry, broad diabetes label, established prescriber relationships, and expanded off-label use for weight management before Wegovy's commercial scale-up